Aroa Biosurgery Limited
AROAF
$0.40
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 8.82% | -105.99% | -2,846.93% | -713.32% | -303.86% |
| Total Depreciation and Amortization | 11.78% | -23.49% | -42.66% | -43.70% | -46.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.81% | 17.43% | 203.05% | 1,376.65% | 1,067.04% |
| Change in Net Operating Assets | 33.26% | 33.26% | 33.26% | 21.95% | 16.18% |
| Cash from Operations | 24.15% | -17.83% | -88.20% | 8.03% | 42.12% |
| Capital Expenditure | 50.27% | 46.50% | 42.71% | 13.66% | -18.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 236.72% | 70.67% | -0.53% | 347.37% | 125.65% |
| Cash from Investing | 4,751.46% | 273.81% | 33.74% | 151.36% | 98.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -19.13% | -17.04% | -14.73% | -15.43% | -16.18% |
| Issuance of Common Stock | 18.97% | -30.77% | -45.05% | -72.39% | -85.85% |
| Repurchase of Common Stock | -- | -- | -- | 0.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -446.75% | -664.81% | -1,206.45% | -19.60% | 79.30% |
| Cash from Financing | -56.54% | -73.70% | -99.97% | -59.51% | -23.38% |
| Foreign Exchange rate Adjustments | 50.24% | 109.26% | -43.50% | -118.51% | -154.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 219.11% | 344.39% | -45.34% | 81.54% | 78.73% |
